Ageo, Japan

Tetsuo Yamaguchi

This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Yamaguchi. Retrieved from https://idiyas.com/inventor/tetsuo-yamaguchi-vmhsh3ei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tetsuo Yamaguchi: Innovator in Pharmaceutical Compositions

Introduction

Tetsuo Yamaguchi is a notable inventor based in Ageo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized pharmaceutical compositions. His work has implications for therapeutic agents used in the circulatory system.

Latest Patents

Yamaguchi holds a patent for "Stabilized pharmaceutical compositions." This patent describes stabilized solid pharmaceutical preparations that incorporate one or more of sodium carbonate, sodium hydrogen carbonate, calcium carbonate, and calcium hydrogen phosphate. These compositions contain a 1,4-dihydropyridine derivative as an active ingredient and are utilized as oral therapeutic agents, especially as coronary vasodilators.

Career Highlights

Yamaguchi is associated with Taisho Pharmaceutical Co., Ltd., where he has contributed to innovative pharmaceutical solutions. His expertise in stabilizing pharmaceutical compositions has positioned him as a key figure in the industry.

Collaborations

Some of Yamaguchi's notable coworkers include Shozo Kouchiwa and Masami Nemoto. Their collaborative efforts have further advanced the research and development of pharmaceutical products.

Conclusion

Tetsuo Yamaguchi's work in pharmaceutical innovations highlights the importance of stabilized compositions in medical treatments. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…